Single Cell Profiling Distinguishes Leukemia-Selective Chemotypes
Hannah L. ThirmaniD, Madeline HayesiD, Laura C. GebeniD, Rebecca A. IhrieiD, Lauren E. BrowniD, John A. Jr. PorcoiD, Jonathan Michael IrishiD
Abstract
A central challenge in chemical biology is to distinguish molecular families in which small structural changes trigger large changes in cell biology. Such families might be ideal scaffolds for developing cell-selective chemical effectors - for example, molecules that activate DNA damage responses in malignant cells while sparing healthy cells. Across closely related structural variants, subtle structural changes have the potential to result in contrasting bioactivity patterns across different cell types. Here, we tested a 600-compound Diversity Set of screening molecules from the Boston University Center for Molecular Discovery (BU-CMD) in a novel phospho-flow assay that tracked fundamental cell biological processes, including DNA damage response, apoptosis, M-phase cell cycle, and protein synthesis in MV411 leukemia cells. Among the chemotypes screened, synthetic congeners of the rocaglate family were especially bioactive. In follow-up studies, 37 rocaglates were selected and deeply characterized using 12 million additional cellular measurements across MV411 leukemia cells and healthy peripheral blood mononuclear cells. Of the selected rocaglates, 92% displayed significant bioactivity in human cells, and 65% selectively induced DNA damage responses in leukemia and not healthy human blood cells. Furthermore, the signaling and cell-type selectivity were connected to structural features of rocaglate subfamilies. In particular, three rocaglates from the rocaglate pyrimidinone (RP) structural subclass were the only molecules that activated exceptional DNA damage responses in leukemia cells without activating a detectable DNA damage response in healthy cells. These results indicate that the RP subset should be extensively characterized for anticancer therapeutic potential as it relates to the DNA damage response. This single cell profiling approach advances a chemical biology platform to dissect how systematic variations in chemical structure can profoundly and differentially impact basic functions of healthy and diseased cells.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 1.55
- Field percentile
- top 17%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
A. Vegvari, J. E. Rodriguez, R. Zubarev·bioRxiv·Apr 21, 2021
- Large Scale Cell Painting Guided Compound Selection Reveals Activity Cliffs and Functional Relationships
Maxime Sanchez, Nicolas Bourriez, … Auguste Genovesio·Communications BiologyPeer-reviewed·Jan 13, 2026
- Cell Painting in activated cells illuminates phenotypic dark space and uncovers novel drug mechanisms of action.
Matylda Zietek, Akshar Lohith, … R. Scott Lokey·bioRxiv·May 23, 2025
- Transcription Factor Activation Profiles (TFAP) identify compounds promoting differentiation of Acute Myeloid Leukemia cell lines
F. Riccio, E. Micarelli, … G. Cesareni·bioRxiv·Jun 22, 2021
- Illuminating Dark Chemical Matter using the Cell Painting Assay
A. Pahl, J. Liu, … H. Waldmann·bioRxiv·May 31, 2023
- JUMP Cell Painting chemical dataset: Morphological map of 115,796 compounds in human cells
Srinivas Niranj Chandrasekaran, Jeanelle Ackerman, … Anne Elizabeth Carpenter·bioRxiv·Mar 23, 2023